↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

127 / 1,666 drugs found* Show info (disease name, etc.) on mouse-over.
 No.   DrugBank   薬物名(臨床試験情報から抽出)   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   Abacavir  5件: Abacavir; Abacavir 300mg twice daily; Abacavir sulfate; Abacavir sulfate, lamivudine and zidovudine; Reverse transcriptase inhibitors: zidovudine, lamivudine, abacavir;   D00891
 D07057 
 -   -   4件:
2,
135,
265,
325
 2   Acetate  81件: Acetate; Leuprorelin acetate; 40 mg glatiramer acetate; Betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 mg im once a day for four days; Flecainide acetate; Oxaloacetate (oaa); Ulipristal acetate; 11c-acetate; 20mg/0.5ml glatiramer acetate; Bazedoxifene acetate; Cyclophosphamide/glatiramer acetate; Dirucotide acetate; Experimental glatiramer acetate; Glatiramer acetate; Glatiramer acetate (db); Glatiramer acetate (ga); Glatiramer acetate (ga) 40 mg; Glatiramer acetate (ol); Glatiramer acetate 150mg enteric coated tablets; Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets; Glatiramer acetate 20 mg; Glatiramer acetate 20 mg, with mitoxantrone; Glatiramer acetate 20 mg/0.5 ml; Glatiramer acetate 40 mg; Glatiramer acetate injection with oral cetirizine hydrochloride; Glatiramer acetate with minocycline; Glatiramer acetate, (copaxone®); Glatiramer acetate, ifn-beta 1a (im), ifn-beta 1a (subcutaneous), and ifn-beta 1b; Glatiramer acetate, n-acetylcysteine; Human interferon beta-1a and glatiramer acetate; Nomegestrol acetate; Plovamer acetate; Prednisone acetate; Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol); Sodium-[o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate; Tocopherol acetate; Depot leuprolide acetate 3.75 mg; Caspofungin acetate; Desmopressin acetate; Lanreotide acetate; Abiraterone acetate; Gonadorelin acetate and triptorelin acetate; Leuprolide acetate (la); Leuprolide acetate 11.25 mg; Leuprolide acetate 3 month depot; Leuprolide acetate 30 mg; Leuprolide acetate 45 mg; Leuprolide acetate depot; Leuprorelin acetate 3.75mg injection; Luphere depot 3.75mg(leuprolide acetate 3.75mg); Lupron (leuprolide acetate); Megestrol acetate; Megestrol acetate tablet; Triptorelin acetate and gonadorelin acetate; Macimorelin acetate; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Cortisone acetate; Hydrocortisone sodium acetate; Sodium acetate; Tetracosactide acetate; 11c acetate; Dichloroacetate; Dichloroacetate sodium; Zuretinol acetate; Etiprednol dicloacetate; Delmitide acetate; L-lysyl-d-prolyl-l-threonine acetate; Sotrastaurin (inn) acetate; Cosyntropin acetate; Tetracosactide hexaacetate; Glatiramer acetate (copaxone®); Zinc acetate; Zinc acetate dihydrate; Tocopheryl acetate; Prednisolone acetate; Prednisone acetate tablets; Desmopressin acetate trihydrate; Phosphate and betamethasone acetate, 2 ml.; [n-trans-3-hexenoyl] human growth hormone releasing factor (1-44) acetate; Loestrin (norethindrone acetate and ethinyl estradiol); Zinc acetate (20mg/d);   -   -   -   40件:
1,
2,
6,
10,
13,
35,
40,
46,
49,
51,
60,
64,
70,
71,
73,
75,
76,
78,
81,
83,
85,
86,
88,
90,
96,
97,
113,
145,
156,
162,
171,
206,
222,
224,
225,
235,
265,
288,
298,
299
 3   Acetylcarnitine  1件: Acetylcarnitine;   -   -   -   3件:
2,
265,
298
 4   Aldesleukin  3件: Aldesleukin; Low-dose aldesleukin (proleukin®); Interleukin-2 (aldesleukin).;   D00748   3件: IL2RA, IL2RB, IL2RG   3件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Pathways in cancer   4件:
2,
49,
65,
97
 5   Anakinra  8件: Anakinra; Anakinra (kineret®); Anakinra (r-methuil-1ra); Anakinra and peg stnf-r1; Kineret® (anakinra); Response to anakinra associated with methotrexate; Anakinra / kineret; Kineret® or anakinra;   D02934   2件: IL1R1, IL1R2   2件: Cytokine-cytokine receptor interaction, Inflammatory mediator regulation of TRP channels   17件:
2,
13,
15,
19,
37,
41,
46,
49,
50,
56,
65,
84,
86,
106,
107,
266,
299
 6   Arimoclomol  1件: Arimoclomol;   D11374   -   -   3件:
2,
15,
19
 7   Arundic acid  1件: Arundic acid;   D06296   -   -   1件:
2
 8   Baclofen  12件: Baclofen; Rs-baclofen; Aert, (r)-baclofen; Arbaclofen; Arbaclofen er tablets; Arbaclofen extended release tablets; Arbaclofen placarbil; Arbaclofen placarbil 15 mg bid; Arbaclofen placarbil 30 mg bid; Arbaclofen placarbil 45 mg bid; Baclofen 20 mg; Baclofen ir;   D00241   2件: GABBR1, GABBR2   3件: GABAergic synapse, Neuroactive ligand-receptor interaction, cAMP signaling pathway   5件:
2,
10,
13,
18,
149
 9   Basiliximab  1件: Basiliximab;   D03058   1件: IL2RA   4件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, JAK-STAT signaling pathway   7件:
2,
50,
65,
66,
97,
222,
228
 10   Betamethasone  6件: Betamethasone; Betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 mg im once a day for four days; Betamethasone acibutate; Intra-articular compound betamethasone; Intraarticular betamethasone; Phosphate and betamethasone acetate, 2 ml.;   D00244
 D00972
 D01357
 D01402
 D01637
 D02032
 D02286 
 1件: NR3C1   1件: Neuroactive ligand-receptor interaction   6件:
2,
46,
65,
90,
96,
235
 11   Biotin  3件: Biotin; D-biotin; Prebiotics (prebiotin prebiotic fiber stick pac);   D00029   -   -   3件:
2,
13,
20
 12   Bosutinib  1件: Bosutinib;   D03252   2件: ABL1, SRC   3件: Chronic myeloid leukemia, ErbB signaling pathway, Pathways in cancer   2件:
2,
67
 13   Botulinum Toxin Type B  3件: Botulinum toxin type b; Botulinum toxin type b (myobloc); Botulinum toxin type b (2500 units / vial);   D02735   1件: SNAP25   1件: Synaptic vesicle cycle   3件:
2,
6,
51
 14   Botulinum toxin type A  3件: Botulinum toxin type a; Clostridium botulinum toxin type a; Botulinum toxin type a (nabota®) injection into the gastrocnemius muscle;   D00783   1件: SNAP25   1件: Synaptic vesicle cycle   13件:
2,
5,
6,
7,
13,
15,
17,
36,
51,
70,
113,
149,
226
 15   Butylphthalide  1件: Butylphthalide;   -   -   -   2件:
2,
6
 16   Caffeine  5件: Caffeine; Caffeine 100-200 mg bid; Caffeine alkaloid; Dextromethorphan and caffeine; Caffeine 100 mg;   D00528
 D01453 
 9件: ADORA1, ADORA2A, PDE1B, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D   4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, cAMP signaling pathway   6件:
2,
6,
46,
78,
96,
97
 17   Cannabidiol  6件: Cannabidiol; Cannabidiol / dronabinol capsule 5 mg+2,5 mg; Cannabidiol capsule 5 mg; Cannabidiol tablet 10 mg; Cannabidiol (cbd); Cannabidiol oral solution;   D10915   2件: CNR1, CNR2   1件: Neuroactive ligand-receptor interaction   14件:
2,
6,
13,
46,
95,
96,
97,
140,
144,
145,
157,
158,
193,
271
 18   Capsaicin  4件: Capsaicin; Capsaicin challenge; Capsaicin vapor; Qutenza (8% capsaicin);   D00250   1件: TRPV1   1件: Neuroactive ligand-receptor interaction   6件:
2,
6,
19,
86,
113,
226
 19   Carbidopa  60件: Carbidopa; Carbidopa-levodopa; Accordion pill carbidopa/levodopa; Accordion pill™ carbidopa/levodopa; Accordion pill™ carbidopa/levodopa 50/400 mg; Accordion pill™ carbidopa/levodopa 50/500 mg; Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg); Carbidopa 20 mg; Carbidopa 27.5 mg; Carbidopa 65 mg capsule; Carbidopa and levodopa 25mg/100mg; Carbidopa fu; Carbidopa levodopa; Carbidopa monohydrate; Carbidopa, levodopa, entacapone; Carbidopa- levodopa; Carbidopa/l-dopa; Carbidopa/l-dopa/entacapone; Carbidopa/levodopa; Carbidopa/levodopa, immediate release; Carbidopa/levodopa/entacapone; Comparator: carbidopa; Continuous intrajejunal infusion of levodopa-carbidopa; Controlled-release levodopa / carbidopa; Entacapone and carbidopa; Immediate release carbidopa/levodopa; Immediate release carbidopa/levodopa 25/100 mg; Levodopa and carbidopa; Levodopa and carbidopa sc solution; Levodopa and carbidopa solution for sc administration; Levodopa carbidopa (lc) oral encapsulated immediate release (ir) tablets; Levodopa carbidopa intestinal gel (lcig); Levodopa, carbidopa, entacapone; Levodopa, carbidopa, odm-104; Levodopa-carbidopa; Levodopa-carbidopa (lc) oral encapsulated immediate release (ir) tablets; Levodopa-carbidopa immediate release (lc-ir) tablets; Levodopa-carbidopa intestinal gel; Levodopa-carbidopa multilayer extended release tablet; Levodopa-carbidopa xl tablet (m); Levodopa-carbidopa-entacapone; Levodopa/carbidopa; Levodopa/carbidopa (sinemet); Levodopa/carbidopa 100/25; Levodopa/carbidopa hydrate; Levodopa/carbidopa solution; Levodopa/carbidopa(200mg/50mg); Levodopa/carbidopa/entacapone; Nd0612 (levodopa/carbidopa solution); Odm-101 105mg carbidopa; Odm-101 65mg carbidopa; Oral levodopa and carbidopa; Oral levodopa/carbidopa; Sinemet (levodopa/carbidopa); Sinemet plus (levodopa/carbidopa); Sinemet® controlled release (carbidopa/levodopa); Stalevo (levodopa/ carbidopa/ entacapone); Stalevo (levodopa/carbidopa/entacapona); Xp21279 and carbidopa (experimental); Levodopa/carbidopa (4:1);   D00558   1件: DDC   2件: Dopaminergic synapse, Serotonergic synapse   8件:
2,
4,
6,
13,
17,
90,
164,
201
 20   Carbonate ion  0件:   -   -   -   10件:
2,
13,
17,
19,
46,
75,
96,
127,
235,
299
 21   Ceftriaxone  1件: Ceftriaxone;   D00924
 D07659 
 -   -   3件:
2,
6,
97
 22   Celecoxib  7件: Celecoxib; Fixed dose combination ciprofloxacin/celecoxib; Celecoxib (celebrex); Celecoxib 200mg capsule; Celecoxib 200 milligrams; Celecoxib 400 milligrams; Celecoxib, celebrex®;   D00567   1件: PTGS2   1件: Arachidonic acid metabolism   9件:
2,
3,
34,
46,
70,
89,
96,
161,
271
 23   Cimetidine  2件: Cimetidine; Cimetidine plus dexpramipexole;   D00295
 D03503 
 1件: HRH2   3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction   1件:
2
 24   Ciprofloxacin  14件: Ciprofloxacin; Fixed dose combination ciprofloxacin/celecoxib; Ciprofloxacin hydrochloride; Cipro (ciprofloxacin, bayq3939); Ciprofloxacin (cipro inhale, bayq3939); Ciprofloxacin (cipro, bayq3939); Ciprofloxacin (ciproxin); Ciprofloxacin dispersion for inhalation; Ciprofloxacin dpi; Ciprofloxacin for inhalation; Ciprofloxacin hydrochloride monohydrate; Oral ciprofloxacin; Oral ciprofloxacin plus inhaled colistin; Po ciprofloxacin;   D00186
 D02216 
 -   -   5件:
2,
60,
96,
97,
299
 25   Colchicine  3件: Colchicine; Colchicine 1 mg oral tablet; Colchicine sprinkle capsules;   D00570   9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8   2件: Gap junction, Phagosome   5件:
2,
42,
56,
93,
266
 26   Copper  4件: Copper; Zinc and copper; Copper histidinate; Copper histidine;   -   -   -   4件:
2,
169,
170,
171
 27   Corticotropin  10件: Corticotropin; Repository corticotropin injection; H.p. acthar gel (repository corticotropin injection); H.p. acthar® gel (repository corticotropin injection); Corticotropin-releasing hormone; Ovine corticotropin-releasing hormone (ocrh); Corticotropin releasing hormone; Repository corticotropin injection -treatment extension; Adrenocorticotropin; Adrenocorticotropin hormone;   D00146   1件: MC2R   3件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Neuroactive ligand-receptor interaction   12件:
2,
13,
46,
49,
50,
66,
75,
78,
84,
145,
193,
222
 28   Creatine  4件: Creatine; Creatine monohydrate; Pyruvate, creatine, niacinamide; Creatine-13c;   -   -   -   12件:
1,
2,
5,
6,
8,
13,
46,
49,
50,
113,
156,
201
 29   Creatinine  1件: Creatinine;   D03600   -   -   3件:
2,
46,
60
 30   Cupric Chloride  0件:   D03612   -   -   4件:
2,
169,
170,
171
 31   Darunavir  1件: Darunavir;   D03656   -   -   1件:
2
 32   Deferiprone  7件: Deferiprone; Deferiprone (ferriprox); Deferiprone 600 mg delayed release tablet; Ferrprox (deferiprone); Deferiprone 80 mg/ml oral solution; Deferiprone 80 mg/ml oral solution (ferriprox); Deferiprone oral solution;   D07416   -   -   5件:
2,
6,
120,
122,
233
 33   Dexmedetomidine  8件: Dexmedetomidine; Dexmedetomidine hydrochloride infusion; Dexmedetomidine group; Dexmedetomidine hydrochloride; Dexmedetomidine and fentanyl; Dexmedetomidine 1; Dexmedetomidine 2; Dexmedetomidine 3;   D00514
 D01205 
 3件: ADRA2A, ADRA2B, ADRA2C   1件: Neuroactive ligand-receptor interaction   11件:
2,
4,
6,
21,
34,
70,
113,
212,
215,
226,
280
 34   Dexpramipexole  5件: Cimetidine plus dexpramipexole; Dexpramipexole; Dexpramipexole (dose 1); Dexpramipexole (dose 2); Dexpramipexole dichydrochloride;   D09886   -   -   1件:
2
 35   Dextran  4件: Dextran; Dextran sulfate sodium; Iron dextran; Iron(iii)- hydroxide dextran complex;   D00060   -   -   5件:
2,
62,
79,
96,
97
 36   Dextromethorphan  9件: Dextromethorphan; Dextromethorphan hbr and quinidine sulfate; Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg; Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg; Dextromethorphan/quinidine 20mg/10mg (dm/q 20mg/10mg); Dimebon + dextromethorphan; Dextromethorphan hydrobromide; Dextromethorphan and caffeine; Dextromethorphan 30 mg;   D00848
 D03742
 D03744 
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   2件: Glutamatergic synapse, Neuroactive ligand-receptor interaction   9件:
2,
6,
8,
13,
46,
78,
96,
97,
156
 37   Dolutegravir  1件: Dolutegravir;   D10066   -   -   1件:
2
 38   Dronabinol  4件: Dronabinol; Cannabidiol / dronabinol capsule 5 mg+2,5 mg; Dronabinol capsule 2,5 mg; Dronabinol capsule 2.5. mg;   D00306   2件: CNR1, CNR2   1件: Neuroactive ligand-receptor interaction   5件:
2,
13,
46,
271,
298
 39   Edaravone  1件: Edaravone;   D01552   -   -   2件:
2,
22
 40   Eperisone  1件: Eperisone;   D01671
 D07898 
 -   -   1件:
2
 41   Erythropoietin  4件: Erythropoietin; Recombinant human erythropoietin(rhepo); Erythropoietin human recombinant (eporh); Recombinant human erythropoietin;   D03231   1件: EPOR   3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway   9件:
2,
6,
13,
22,
46,
47,
70,
95,
96
 42   Escitalopram  3件: Escitalopram; Oral escitalopram; Escitalopram oxalate antidepressant;   D02567
 D07704
 D07913 
 1件: SLC6A4   1件: Serotonergic synapse   3件:
2,
6,
13
 43   Esketamine  2件: Esketamine; Esketamine hydrochloride;   D07283   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   2件: Glutamatergic synapse, Neuroactive ligand-receptor interaction   3件:
2,
4,
70
 44   Ethanol  14件: Endocannabinoid palmitoylethanolamide (pea); Palmitoylethanolamide; Treprostinil diethanolamine; Ut-15c (treprostinil diethanolamine); Ut-15c sr (treprostinil diethanolamine); Andrographis paniculata (ethanol extract); Ethanol; Ethanol (96 per cent); Ethanol 96% gel; Ethanol 98% solution; Ethanol bp; Ethanol gel; Ethanolamine; Ethanolamine oleate;   D00068
 D02798
 D04855
 D06542 
 -   -   49件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
58,
61,
63,
64,
65,
66,
81,
84,
85,
86,
88,
95,
96,
97,
113,
145,
162,
164,
222,
224,
228,
251,
279,
280,
283,
284,
285,
288,
298,
299,
300,
331
 45   Ezogabine  4件: Ezogabine; Ezogabine (us only); Ezogabine/retigabine; Retigabine/ezogabine;   D09569   5件: KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5   1件: Cholinergic synapse   2件:
2,
144
 46   Fasudil  1件: Fasudil;   D07941   2件: ROCK1, ROCK2   4件: Oxytocin signaling pathway, Regulation of actin cytoskeleton, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   1件:
2
 47   Febuxostat  1件: Febuxostat;   D01206   1件: XDH   2件: Peroxisome, Purine metabolism   3件:
2,
6,
13
 48   Filgrastim  7件: Filgrastim; Pegfilgrastim; Ep2006 (filgrastim); Filgrastim hexal; Filgrastim, alemtuzumab; Granulocyte colony-stimulating factor (filgrastim); Filgrastim (g-csf);   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   28件:
2,
6,
13,
16,
25,
26,
28,
34,
35,
36,
40,
41,
42,
45,
46,
49,
51,
60,
62,
65,
85,
96,
113,
164,
283,
284,
285,
331
 49   Fingolimod  7件: 0,5 mg fingolimod; Fingolimod; Fingolimod (fty720); Fingolimod 0.5 mg; Fingolimod 1.25 mg; Fingolimod hydrochloride; Fingolimodi;   D10001   1件: S1PR1   2件: Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   4件:
2,
13,
14,
156
 50   Glatiramer  23件: 40 mg glatiramer acetate; Glatiramer; 20mg/0.5ml glatiramer acetate; Cyclophosphamide/glatiramer acetate; Experimental glatiramer acetate; Glatiramer acetate; Glatiramer acetate (db); Glatiramer acetate (ga); Glatiramer acetate (ga) 40 mg; Glatiramer acetate (ol); Glatiramer acetate 150mg enteric coated tablets; Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets; Glatiramer acetate 20 mg; Glatiramer acetate 20 mg, with mitoxantrone; Glatiramer acetate 20 mg/0.5 ml; Glatiramer acetate 40 mg; Glatiramer acetate injection with oral cetirizine hydrochloride; Glatiramer acetate with minocycline; Glatiramer acetate, (copaxone®); Glatiramer acetate, ifn-beta 1a (im), ifn-beta 1a (subcutaneous), and ifn-beta 1b; Glatiramer acetate, n-acetylcysteine; Human interferon beta-1a and glatiramer acetate; Glatiramer acetate (copaxone®);   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   1件: Antigen processing and presentation   4件:
2,
13,
96,
156
 51   Gold  3件: Gold; Gold nanocrystals; Sodium aurothiomalate (intramuscular gold);   -   -   -   5件:
2,
6,
13,
46,
171
 52   Guanabenz  2件: Guanabenz; Guanabenz acetato;   D04375   3件: ADRA2A, ADRA2B, ADRA2C   1件: Neuroactive ligand-receptor interaction   2件:
2,
13
 53   Human Serum Albumin  4件: Human serum albumin; Human serum albumin (hsa) fused to recombinant human growth hormone (hgh); Human serum albumin (hsa) fused to somatropin; Recombinant human serum albumin (hsa) fused to human growth hormone (hgh);   D05424   -   -   3件:
2,
78,
96
 54   Human interleukin-2  3件: Human interleukin-2; Recombinant human interleukin-2 (rhil-2); Anti-human interleukin-23 monoclonal antibody;   -   -   -   14件:
2,
13,
35,
46,
49,
51,
55,
56,
63,
65,
95,
96,
97,
271
 55   Ibudilast  1件: Ibudilast;   D01385   8件: CYSLTR1, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PTGIR   4件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   2件:
2,
13
 56   Immune Globulin Human  0件:   -   -   -   20件:
2,
11,
13,
14,
17,
18,
35,
38,
39,
43,
45,
49,
50,
51,
63,
65,
85,
164,
296,
309
 57   Inosine  2件: Inosine; 1) inosine 5'-monophosphate;   D00054   -   -   4件:
2,
6,
13,
17
 58   Iodide I-123  0件:   -   -   -   2件:
2,
6
 59   Ioflupane I-123  0件:   D10014   -   -   3件:
2,
5,
6
 60   Lacosamide  1件: Lacosamide;   D07299   -   -   3件:
2,
46,
149
 61   Lactose  4件: Lactose; Lactose monohydrate; 2'-fucosyllactose; Lactose in water;   D00046
 D03226 
 -   -   6件:
2,
6,
13,
97,
228,
310
 62   Lamivudine  7件: Lamivudine; Zidovudine/lamivudine; Abacavir sulfate, lamivudine and zidovudine; Combivir (zidovudine [azt] / lamivudine [3tc]); Lamivudine/zidovudine; Lopinavir/ritonavir + zidovudine + lamivudine; Reverse transcriptase inhibitors: zidovudine, lamivudine, abacavir;   D00353   -   -   7件:
2,
26,
42,
46,
135,
265,
325
 63   Lenograstim  3件: Lenograstim; Granocyte - 34 million iu (lenograstim rhug-csf); Granocyte lenograstim;   D03247   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   3件:
2,
57,
65
 64   Leuprolide  11件: Leuprolide; Depot leuprolide acetate 3.75 mg; Leuprolide (gnrh agonists); Leuprolide acetate (la); Leuprolide acetate 11.25 mg; Leuprolide acetate 3 month depot; Leuprolide acetate 30 mg; Leuprolide acetate 45 mg; Leuprolide acetate depot; Luphere depot 3.75mg(leuprolide acetate 3.75mg); Lupron (leuprolide acetate);   D00989
 D08113 
 1件: GNRHR   2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction   5件:
1,
2,
3,
51,
76
 65   Levetiracetam  1件: Levetiracetam;   D00709   1件: SV2A   1件: ECM-receptor interaction   4件:
2,
4,
6,
13
 66   Levodopa  89件: Carbidopa-levodopa; Levodopa; Accordion pill carbidopa/levodopa; Accordion pill™ carbidopa/levodopa; Accordion pill™ carbidopa/levodopa 50/400 mg; Accordion pill™ carbidopa/levodopa 50/500 mg; Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg); Carbidopa and levodopa 25mg/100mg; Carbidopa levodopa; Carbidopa, levodopa, entacapone; Carbidopa- levodopa; Carbidopa/levodopa; Carbidopa/levodopa, immediate release; Carbidopa/levodopa/entacapone; Comparator: levodopa; Continuous intrajejunal infusion of levodopa-carbidopa; Controlled-release levodopa / carbidopa; Immediate release carbidopa/levodopa; Immediate release carbidopa/levodopa 25/100 mg; Intravenous levodopa; Iv levodopa; Levodopa (delivered intravenously); Levodopa (drug), intraduodenal administration; Levodopa (l-dopa); Levodopa (l-dopa) + standard care; Levodopa / benserazid; Levodopa / benserazide 200 + 50 mg; Levodopa 100 mg / benserazide 25 mg; Levodopa 100 mg a cap; Levodopa 125 mg a cap; Levodopa 150 mg a cap; Levodopa 25mg/100mg; Levodopa 75 mg a cap; Levodopa acute challenge; Levodopa and carbidopa; Levodopa and carbidopa sc solution; Levodopa and carbidopa solution for sc administration; Levodopa and decarboxylase inhibitor; Levodopa and domperidone; Levodopa benserazide madopar; Levodopa benserazide teva italia; Levodopa carbidopa (lc) oral encapsulated immediate release (ir) tablets; Levodopa carbidopa intestinal gel (lcig); Levodopa cr (controlled release); Levodopa cyclops; Levodopa dc.it fu; Levodopa dispersible; Levodopa infusion; Levodopa mr; Levodopa powder for inhalation; Levodopa, carbidopa, entacapone; Levodopa, carbidopa, odm-104; Levodopa, decarboxylase inhibitor and comt inhibitor; Levodopa-carbidopa; Levodopa-carbidopa (lc) oral encapsulated immediate release (ir) tablets; Levodopa-carbidopa immediate release (lc-ir) tablets; Levodopa-carbidopa intestinal gel; Levodopa-carbidopa multilayer extended release tablet; Levodopa-carbidopa xl tablet (m); Levodopa-carbidopa-entacapone; Levodopa/benserazide; Levodopa/benserazide 100/25 mg; Levodopa/benzeraside; Levodopa/benzerazide; Levodopa/carbidopa; Levodopa/carbidopa (sinemet); Levodopa/carbidopa 100/25; Levodopa/carbidopa hydrate; Levodopa/carbidopa solution; Levodopa/carbidopa(200mg/50mg); Levodopa/carbidopa/entacapone; Levodopa/ddci; Melevodopa; Melevodopa and decarboxylase inhibitor; Nacom levodopa+cardidopa; Nd0612 (levodopa/carbidopa solution); Oral levodopa and carbidopa; Oral levodopa/carbidopa; Rasagiline mesylate with levodopa; Safinamide + levodopa; Sinemet (levodopa/carbidopa); Sinemet plus (levodopa/carbidopa); Sinemet® controlled release (carbidopa/levodopa); Stalevo (levodopa/ carbidopa/ entacapone); Stalevo (levodopa/carbidopa/entacapona); Tvp-1012 (1 mg/day) with levodopa; Tvp-1012 1mg with levodopa; Levodopa test; Levodopa/carbidopa (4:1);   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   4件: Calcium signaling pathway, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Parkinson disease   7件:
2,
4,
6,
17,
90,
164,
201
 67   Levosimendan  2件: Levosimendan; Oral levosimendan;   D04720   2件: PDE3A, PDE3B   3件: Apelin signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
2
 68   Lipoic Acid  8件: Alpha-lipoic acid; Lipoic acid; Alpha-lipoic acid and l-acetyl carnitine; Alpha lipoic acid; Lipoic acid (la) with fish oil and la without fish oil; Lipoic acid and omega-3 fatty acids; Oral lipoic acid (la); R lipoic acid;   D00048
 D00086 
 -   -   5件:
2,
5,
13,
14,
20
 69   Lithium carbonate  1件: Lithium carbonate;   D00801   -   -   8件:
2,
5,
7,
8,
13,
17,
19,
127
 70   Lithium citrate  0件:   D04749   -   -   4件:
2,
5,
7,
8
 71   Masitinib  10件: Masitinib; Masitinib (3.0); Masitinib (4.5); Masitinib (6.0); Masitinib mesylate; Masitinib 100mg; Masitinib 200mg; Masitinib (ab1010); Masitinib 3 mg; Masitinib 6.0 mg;   D10229   1件: KIT   2件: MAPK signaling pathway, Pathways in cancer   6件:
2,
5,
6,
13,
46,
96
 72   Medical Cannabis  0件:   -   -   -   6件:
2,
6,
13,
90,
96,
97
 73   Memantine  3件: Memantine; Memantine (ebixa); Memantine hydrochloride;   D04905
 D08174 
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   3件: Alzheimer disease, Glutamatergic synapse, Neuroactive ligand-receptor interaction   7件:
2,
6,
8,
13,
49,
127,
205
 74   Methamidophos  0件:   -   -   -   12件:
2,
11,
13,
19,
46,
49,
58,
70,
85,
98,
298,
300
 75   Methylcobalamin  1件: Methylcobalamin;   D03246   -   -   1件:
2
 76   Methylprednisolone  29件: Methylprednisolone; Iv methylprednisolone; Iv methylprednisolone (steroids); Megadose oral methylprednisolone; Methylprednisolone (drug); Methylprednisolone hemisuccinate; Methylprednisolone iv; Methylprednisolone sodium hemisuccinate; Methylprednisolone sodium succinate; Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Prednisone, methylprednisolone,cyclophosphamides; Methylprednisolone (or other glucocorticoid); Prednisone (and methylprednisolone); Infliximab, methylprednisolone, methotrexate; Methotrexate + methylprednisolone; Administration of rituximab and methylprednisolone; Methylprednisolone (mp); Corticosteroid treatment (methylprednisolone or prednisolone); Methylprednisolone or prednisolone; Methylprednisolone (mp) or prednisone (pred); Methylprednisolone mylan générique; Methylprednisolone pulse; Methylprednisolone(intravenously in the 1st-2nd-3rd month ); Methylprednisolone(intravenously in the 1st-3rd-5th month); Methylprednisolone bolus iv 15 mg/kg/d for 3 days.; Methylprednisolone or budesonide; Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone; Intravenous methylprednisolone; Intravenous (i.v.) methylprednisolone 1000 mg, total 9;   D00407
 D00751
 D00979
 D05000
 D05001
 D05002 
 1件: NR3C1   1件: Neuroactive ligand-receptor interaction   36件:
2,
13,
25,
26,
35,
38,
39,
40,
41,
42,
43,
45,
46,
49,
50,
51,
60,
63,
64,
65,
66,
83,
84,
86,
96,
97,
145,
164,
220,
222,
224,
271,
283,
284,
285,
296
 77   Mexiletine  1件: Mexiletine;   D00639
 D08215 
 2件: SCN1A, SCN5A   2件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse   5件:
1,
2,
10,
113,
114
 78   Midazolam  6件: Midazolam; Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin); Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142; S-ketamine & midazolam; Midazolam 2 mg; Midazolam 3 mg;   D00550
 D00696
 D05028 
 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   2件: GABAergic synapse, Neuroactive ligand-receptor interaction   10件:
2,
3,
6,
13,
46,
70,
96,
97,
231,
298
 79   Minocycline  7件: Minocycline; Glatiramer acetate with minocycline; Minocycline 100 mg film-coated tablets; Minocycline hydrochloride; Combination of minocycline and mtx or mtx alone; Lovastatin, then minocycline/lovastatin; Minocycline, then minocycline/lovastatin;   D00850
 D05045 
 -   -   14件:
2,
6,
8,
13,
46,
84,
85,
90,
94,
162,
201,
206,
280,
299
 80   Moxifloxacin  6件: Moxifloxacin; Moxifloxacin infusion; Moxifloxacina cloridrato; Avelox- moxifloxacin; Moxifloxacin 400 mg; Moxifloxacin hydrochloride;   D00874
 D08237 
 -   -   8件:
2,
6,
46,
49,
85,
86,
240,
299
 81   Mycophenolate mofetil  17件: Mycophenolate mofetil; Mycophenolate mofetil (cellcept); Mycophenolate mofetil [cellcept]; Mycophenolate mofetil (mmf) 3 g/day; Mycophenolate mofetil 2 g/day; Cellcept (mycophenolate mofetil); Mycophenolate mofetil,methotrexate; Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate); Mycophenolate mofetil (mmf); Mycophenolate mofetil plus lower dose of prednisone; Azathioprine or mycophenolate mofetil; Mycophenolate mofetil orally 1000 mg twice a day (bid); Mycophenolate mofetil, low dose steroid; Prednisolone and mycophenolate mofetil; Mycophenolate mofetil(mmf); Cyclosporine combine with mycophenolate mofetil; Prednisone and mycophenolate mofetil;   D00752
 D05094
 D05095 
 2件: IMPDH1, IMPDH2   1件: Purine metabolism   32件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300
 82   Mycophenolic acid  2件: Mycophenolic acid; Mycophenolic acid mofetil;   D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   34件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
84,
85,
95,
96,
162,
164,
222,
224,
226,
228,
234,
283,
284,
285,
300
 83   Olanzapine  1件: Olanzapine;   D00454
 D06623 
 11件: ADRA1A, ADRA1B, ADRA1D, DRD2, DRD3, DRD4, HRH1, HTR2A, HTR2B, HTR2C, HTR6   3件: Dopaminergic synapse, Neuroactive ligand-receptor interaction, Serotonergic synapse   2件:
2,
8
 84   Ozanezumab  1件: Ozanezumab;   D10331   -   -   1件:
2
 85   Palmidrol  0件:   D08328   -   -   1件:
2
 86   Perampanel  3件: Perampanel; 2 mg perampanel; 4 mg perampanel;   D08964   4件: GRIA1, GRIA2, GRIA3, GRIA4   3件: Dopaminergic synapse, Glutamatergic synapse, Neuroactive ligand-receptor interaction   3件:
2,
6,
144
 87   Phenylbutyric acid  0件:   D05868   -   -   10件:
2,
3,
6,
8,
93,
94,
244,
251,
297,
299
 88   Phosphate ion  0件:   -   -   -   29件:
2,
3,
11,
12,
13,
28,
36,
46,
49,
51,
53,
60,
62,
65,
70,
78,
81,
83,
90,
96,
97,
164,
235,
256,
283,
284,
285,
286,
299
 89   Pimozide  4件: Pimozide; Pimozide 2 mg per day; Pimozide 2mg/day (current) or 4 mg/day (study initiation); Pimozide 4 mg per day;   D00560   2件: DRD2, DRD3   2件: Dopaminergic synapse, Neuroactive ligand-receptor interaction   1件:
2
 90   Pioglitazone  6件: Pioglitazone; Pioglitazone and tretinoin; Tretinoin and pioglitazone hcl; Actos (pioglitazone); Pioglitazone 15 mg; Pioglitazone or metformin;   D00945
 D08378 
 1件: PPARG   2件: AMPK signaling pathway, PPAR signaling pathway   17件:
2,
6,
13,
15,
20,
46,
49,
65,
67,
78,
81,
86,
96,
229,
265,
298,
299
 91   Pleconaril  1件: Pleconaril;   D05528   -   -   1件:
2
 92   Pramipexole  25件: Cimetidine plus dexpramipexole; Dexpramipexole; Dexpramipexole (dose 1); Dexpramipexole (dose 2); Dexpramipexole dichydrochloride; Pramipexole; R(+) pramipexole dihydrochloride monohydrate; Dopamine agonists (pramipexole, ropirinole); Mirapex (pramipexole); P2b001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg),; P2b001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg),; Pramipexole 0.125 mg tablets; Pramipexole 0.5 mg tablets; Pramipexole dihydrochloride; Pramipexole dihydrochloride extended-release tablets; Pramipexole dihydrochloride monohydrate; Pramipexole dihydrochloride monohydrate extended release; Pramipexole er; Pramipexole extended release; Pramipexole extended release tablet; Pramipexole immediate release; Pramipexole immediate release tablet; Pramipexole ir; Pramipexole or ropinirole; Pramipexole sr;   D00559
 D05575 
 3件: DRD2, DRD3, DRD4   3件: Dopaminergic synapse, Neuroactive ligand-receptor interaction, Parkinson disease   2件:
2,
6
 93   Prednisone  59件: Prednisone; Prednisone - azathioprine; Prednisone alone; Granulocyte-colony stimulating factor (g-csf) and prednisone; Prednisone/prednisolone; Prednisone acetate; Prednisone, cyclophosphamide; Over encapsulated prednisone; Prednisone and ustekinumab treatment; Prednisone capsules; Prednisone tablets usp, 1 mg; Prednisone tablets usp, 2.5 mg; Prednisone tablets usp, 5 mg; Prednisone tablets, usp; Prednisone therapy and pharmacokinetic; Prednisone treatment; Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Prednisone, methylprednisolone,cyclophosphamides; Prednisone (and methylprednisolone); 0 mg prednisone; 5 mg prednisone; Methylprednisone; Prednisone 15 mg; Prednisone 5 mg; Prednisone 7.5 mg; Rayos (delayed-release prednisone); Corticosteroids (prednisone or prednisolone); Cyclophosphamide-prednisone-azathioprine; Oral prednisone 5mg; Prednisone discontinuation; Chinese herb prescription granule plus prednisone; Enalapril valsartan methylprednisone; Hormone (prednisone); Leflunomide 20 mg+prednisone 0.5mg/kg/d; Methylprednisolone (mp) or prednisone (pred); Mycophenolate mofetil plus lower dose of prednisone; Prednisone + inhibace/cozaar; Prednisone and cyclophosphamide; Prednisone arrow 20mg; Prednisone arrow 5 mg; Prednisone in full dose; Prednisone or prednisolone; Prednisone plus cyclophosphamide; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Glucocorticoid (prednisone or prednisolone); Hydroxychloroquine + prednisone; Azathioprine/prednisone; 5-asa, prednisone, azathioprine or remicade; 5-aminosalicylic acid(5-asa) and/or prednisone; Treatment systemic therapy (prednisone); Treatment with systemic therapy (prednisone); Prednisone 0,5 mg/kg orally on alternate days; Prednisone, fk506, mmf; Tacrolimus combined with prednisone; Prednisone acetate tablets; Oral prednisone; Sotatercept with prednisone boost; Prednisone and mycophenolate mofetil; Thalidomide, cyclophosphamide and prednisone;   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   44件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
61,
63,
64,
65,
66,
81,
84,
85,
86,
95,
96,
97,
113,
145,
162,
164,
222,
224,
228,
251,
283,
284,
285,
288,
299,
300,
331
 94   Pyrimethamine  2件: Pyrimethamine; Fansidar (pyrimethamine and sulfadoxine);   D00488   -   -   4件:
2,
4,
19,
65
 95   Quinidine  5件: Dextromethorphan hbr and quinidine sulfate; Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg; Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg; Quinidine; Dextromethorphan/quinidine 20mg/10mg (dm/q 20mg/10mg);   D00642
 D00643
 D02272
 D08458 
 2件: SCN1A, SCN5A   2件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse   3件:
2,
8,
13
 96   Rabeprazole  1件: Rabeprazole;   D00724
 D08463 
 2件: ATP4A, ATP4B   2件: Collecting duct acid secretion, Gastric acid secretion   2件:
2,
51
 97   Ranolazine  7件: Ranolazine; Ranolazine 1000 mg; Ranolazine 500 mg; Ranolazine 1000 mg pr tablets; Ranolazine 500 mg pr tablets; Ranolazine 750 mg pr tablets; Ranolazine pr (prolonged-release) 500 mg 1 tablet bis in die and 750 mg 1 tablet bis in die;   D05700
 D05701 
 -   -   6件:
2,
58,
86,
113,
114,
130
 98   Rasagiline  16件: Rasagiline; Rasagiline mesilate; 1.0 mg rasagiline mesylate; Group r rasagiline; Group r+ad rasagiline + antidepressant; P2b001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg),; P2b001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg),; Rasagiline 1 mg capsule; Rasagiline 1mg tablet; Rasagiline 2 mg tablet; Rasagiline mesylate; Rasagiline mesylate 1.0 mg; Rasagiline mesylate plus mirapex; Rasagiline mesylate with levodopa; Rasagiline mesylate with requip; Rasagiline tablets;   D02562
 D08469
 D10829 
 1件: MAOB   2件: Dopaminergic synapse, Serotonergic synapse   4件:
2,
5,
6,
17
 99   Reldesemtiv  0件:   D11363   1件: TNNC2   1件: Calcium signaling pathway   2件:
2,
3
 100   Ribavirin  1件: Ribavirin;   D00423   -   -   2件:
2,
96
 101   Riluzole  5件: Riluzole; Riluzole 50 mg; Riluzole 50 mg (part b); Riluzole oral soluble film; Riluzole oral soluble film (rosf) 50 mg;   D00775   14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   4件: Amyotrophic lateral sclerosis (ALS), Dopaminergic synapse, Glutamatergic synapse, Neuroactive ligand-receptor interaction   7件:
2,
3,
5,
8,
13,
17,
206
 102   Ritonavir  9件: Ritonavir; Saquinavir and ritonavir; Lopinavir / ritonavir; Atazanavir (atv) + ritonavir (rtv), continuation of backbone 2 nucleoside reverse transcriptase inhibitor (nrtis); Atazanavir/ritonavir; Lopinavir/ritonavir; Lopinavir/ritonavir + nevirapine; Lopinavir/ritonavir + zidovudine + lamivudine; Ritonavir (norvir);   D00427   -   -   5件:
2,
86,
130,
265,
299
 103   Scopolamine  1件: Scopolamine;   D00138   5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   3件: Cholinergic synapse, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
2
 104   Serine  4件: L-serine; Serine; D-serine; D-serine (~2g/day);   D00016   -   -   3件:
2,
6,
86
 105   Serotonin  2件: Selective serotonin uptake inhibitors (ssri); Serotonin;   -   -   -   1件:
2
 106   Sirolimus  16件: Sirolimus; Temsirolimus; Temsirolimus tablets; Sirolimus 2 mg; Skincerity plus sirolimus/rapamycin; Skinercity plus sirolimus/rapamycin; Sirolimus (formerly known as rapamycin); Sirolimus 2%; Sirolimus, 2%; Rapamycin, sirolimus; Sirolimus and hydroxychloroquine; Sirolimus 0.2%; Sirolimus 0.4%; Sirolimus 0,1% crème; Sirolimus oral liquid product 1mg/ml; Topical 0.1% sirolimus;   D00753   1件: MTOR   2件: Pathways in cancer, mTOR signaling pathway   36件:
2,
13,
15,
17,
34,
35,
36,
46,
49,
51,
60,
61,
62,
63,
65,
66,
67,
85,
86,
89,
96,
98,
137,
157,
158,
192,
222,
256,
277,
278,
279,
280,
281,
283,
285,
331
 107   Somatotropin  3件: Recombinant human somatotropin; Somatotropin; Somatotropine;   D02691   1件: GHR   3件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction   18件:
2,
3,
13,
19,
46,
74,
75,
78,
96,
113,
191,
193,
195,
236,
265,
274,
276,
299
 108   Sulfate ion  0件:   -   -   -   22件:
2,
6,
11,
13,
26,
34,
36,
46,
49,
60,
61,
64,
66,
79,
86,
96,
222,
226,
265,
296,
297,
299
 109   TRO19622  2件: Tro19622; Olesoxime (tro19622);   -   -   -   3件:
2,
3,
13
 110   Tacrolimus  13件: Tacrolimus; Tacrolimus capsule; Interferon beta-1b and tacrolimus; Non-mtx dmards (e.g. sulfasalazine, leflunomide, bucillamine, tacrolimus, or mizoribin); Tacrolimus (prograf®); Tacrolimus with methotrexate; Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf; Lcp-tacro (tacrolimus); Rectal tacrolimus; Tacrolimus capsules; Tacrolimus combined with prednisone; Tacrolimus and mmf; Tacrolimus prolonged-release hard capsules;   D00107
 D08556 
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   30件:
2,
11,
13,
36,
46,
49,
50,
51,
53,
60,
61,
62,
65,
66,
85,
86,
95,
96,
97,
113,
151,
158,
164,
222,
224,
226,
228,
283,
284,
299
 111   Talampanel  1件: Talampanel;   D02696   4件: GRIA1, GRIA2, GRIA3, GRIA4   3件: Dopaminergic synapse, Glutamatergic synapse, Neuroactive ligand-receptor interaction   2件:
2,
6
 112   Tamoxifen  3件: Tamoxifen; Tamoxifen 40 mg daily for one year; Tamoxifen citrate;   D00966
 D08559 
 2件: ESR1, ESR2   3件: Breast cancer, Estrogen signaling pathway, Pathways in cancer   4件:
2,
86,
113,
227
 113   Tauroursodeoxycholic acid  2件: Tauroursodeoxycholic acid; Tauroursodeoxycholic acid capsules;   -   -   -   4件:
2,
13,
93,
299
 114   Tenofovir  10件: Tenofovir; Tenofovir alafenamide; Tenofovir alafenamide (taf); Tenofovir-emtricitabine; Emtricitabine (ftc)/tenofovir disoproxil (tdf); Tenofovir disoproxil; Emtricitabine/tenofovir; Tenofovir df; Tenofovir disoproxil fumarate; Tenofovir (tdf) and emtricitabine (ftc);   D06074   -   -   5件:
2,
25,
93,
265,
325
 115   Tenofovir alafenamide  2件: Tenofovir alafenamide; Tenofovir alafenamide (taf);   D10428   -   -   1件:
2
 116   Testosterone  7件: Testosterone; Nebido® testosterone undecanoate 1000 mg/4 ml solution for injection; Testosterone undecanoate; Testosterone plus somatropin; Transdermal testosterone gel; Sustanon (testosterone); Testosterone enanthate;   D00075
 D00957
 D00958
 D00959
 D06085
 D06087 
 1件: AR   2件: Oocyte meiosis, Pathways in cancer   7件:
1,
2,
3,
13,
78,
113,
265
 117   Thalidomide  9件: Thalidomide; Thalidomide (drug); Fpf 300 (thalidomide); Melphalan, thalidomide and dexamethasone; Thalidomide pharmion; Thalidomide celgene - 50 mg capsula rigida - uso orale - blister (pvc/pe/aclar/alu) 28 capsule; Thalidomide 100mg; Thalidomide 150mg; Thalidomide, cyclophosphamide and prednisone;   D00754   1件: TNF   4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, NF-kappa B signaling pathway, TNF signaling pathway   18件:
2,
16,
20,
28,
49,
51,
53,
65,
84,
85,
94,
96,
97,
227,
271,
280,
298,
331
 118   Tirasemtiv  1件: Tirasemtiv;   D10327   -   -   1件:
2
 119   Tocilizumab  26件: Tocilizumab; Tocilizumab injection; Tocilizumab (mra-sc); Corticoids+ tocilizumab 8mg/kg/4 weeks; Tocilizumab + glucocorticoids (gcs); Tocilizumab sc; Tocilizumab treatment; Abatacept, rituximab or tocilizumab; Decrease tocilizumab, abatacept; Intra-articular tocilizumab; Mra (tocilizumab); Mra(tocilizumab); Subcutaneous tocilizumab; Tocilizumab (actemra®); Tocilizumab + methotrexate(mtx); Tocilizumab 162 mg; Tocilizumab 162mg/0.9ml jeringa sc; Tocilizumab [roactemra/actemra]; Tocilizumab [roactemra]; Tocilizumab prefilled syringe; Tocilizumab+methotrexate(mtx); Tocilizumab, abatacept; Tocilizumabum; Tocilizumab sc 162 mg/0.9 ml prefilled syringe with safety device (pfs); Inn-tocilizumab; Tocilizumab infusion roacemtra (eu);   D02596   1件: IL6R   3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway   16件:
2,
13,
40,
41,
43,
46,
50,
51,
53,
54,
55,
86,
107,
266,
271,
331
 120   Tretinoin  3件: Pioglitazone and tretinoin; Tretinoin; Tretinoin and pioglitazone hcl;   D00094   3件: PML, RARA, RARB   4件: Acute myeloid leukemia, Pathways in cancer, Th17 cell differentiation, Transcriptional misregulation in cancer   5件:
2,
63,
75,
94,
231
 121   Triheptanoin  5件: Triheptanoin; Triheptanoin 1g/kg/day; Triheptanoin oil; Triheptanoina; Ux007 (triheptanoin);   D11465   -   -   10件:
2,
8,
120,
149,
156,
248,
256,
257,
317,
324
 122   Ubidecarenone  0件:   D01065   -   -   12件:
2,
5,
6,
8,
10,
46,
57,
86,
113,
193,
214,
215
 123   Valproic Acid  3件: Valproic acid; Valproic acid (vpa); Valproic acid and levocarnitine;   D00399   6件: ABAT, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2   2件: Calcium signaling pathway, GABAergic synapse   14件:
2,
3,
5,
8,
26,
34,
65,
89,
90,
102,
222,
233,
256,
331
 124   Vitamin E  8件: Vitamin e; Coenzyme q10 with vitamin e; Vitamin e/selenium; Omega-3 and vitamin e supplementation; Vitamin e 800iu; Vitamin c 10mg/kg vitamin e 10 mg/kg; Vitamin e - tgps; Vitamin e supplement;   D02331   -   -   12件:
2,
6,
13,
20,
46,
49,
90,
96,
97,
206,
299,
317
 125   Water  13件: 5% glucose water solution; Water; Pseudoephedrine + 480 ml water; Pseudoephedrine + 50 ml water; 15 o water; Water for injection; 15-o labeled water; Pl 12185/0002 & pl 12185/0005(water for injection); Dextrose, 5% in water; High water intake; Lactose in water; Water for injections; Water for injections, ep;   D00001   -   -   22件:
2,
5,
6,
13,
17,
19,
28,
35,
46,
53,
57,
63,
65,
67,
78,
84,
97,
193,
226,
271,
278,
299
 126   Zinc  8件: Zinc; Zinc and copper; Adeno-associated virus serotype 2/6 encoding left side-zinc finger nuclease (zfn1), sb-a6p-zleft vector; Adeno-associated virus serotype 2/6 encoding right side-zinc finger nuclease (zfn2), sb-a6p-zright vector; Zinc acetate; Zinc acetate dihydrate; Zinc gluconate; Zinc acetate (20mg/d);   -   -   -   4件:
2,
19,
171,
299
 127   Zinc chloride  0件:   D02058   -   -   4件:
2,
19,
171,
299

先頭へ